Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United States
Michele K. Dougherty; Issam Zineh; Leah Christl
Author Information: U.S. Food and Drug Administration, Office of New Drugs, Center for Drug Evaluation and Research
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.